Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,870 public trials 2,109 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

NCT05375903

Conditions
Bladder Cancer, Carcinoma, Carcinoma in Situ of Bladder, +18 more
Locations
  • Arkansas Urology Little Rock, Arkansas, United States
  • UCLA - University of California Los Angeles, California, United States
  • Florida Urology Partners, LLC Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Completed

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

NCT03768414

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +27 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 692 locations
View Trial Details
Completed

A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer

NCT05337137

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • Local Institution - 0042 Los Angeles, California, United States
  • Local Institution - 0039 Los Angeles, California, United States
  • Local Institution - 0034 San Francisco, California, United States
  • Local Institution - 0030 Washington D.C., District of Columbia, United States
View all 61 locations
View Trial Details
Completed

A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

NCT04567615

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • Local Institution - 0010 Ciudad de Buenos Aires, Buenos Aires, Argentina
  • Local Institution - 0019 Buenos Aires, Distrito Federal, Argentina
  • Local Institution - 0017 Rosario, Santa Fe Province, Argentina
  • Local Institution - 0063 San Miguel de Tucumán, Tucumán Province, Argentina
View all 65 locations
View Trial Details

Related conditions